June 15, 2023 | By John Raslavsky | Cirrhosis, Clinical Trials, Liver Disease, Liver Health, Volunteering in Research | Cirrhosis, Clinical research, Clinical trials, Fatty Liver Disease, liver health, Liver research, Liver Scarring
Liver cirrhosis is a chronic and potentially life-threatening condition affecting many worldwide and in Arizona. Historically, men have been disproportionately affected by liver cirrhosis. Studies show that death rates amongst men with liver cirrhosis are twice as high as women. …
July 1, 2022 | By John Raslavsky | Cirrhosis, Clinical Research, NASH | Blog, Clinical trials, Fatty Liver Disease, liver health, Liver research
At their very root, non-alcoholic steatohepatitis (NASH) and cirrhosis are two medical conditions that affect the liver. However, this seemingly separate duo shares more in common than you may think. When NASH and cirrhosis get together, your liver is at …
September 29, 2021 | By John Raslavsky | Cirrhosis, Fibroscan | Blog, Clinical trials, NAFLD, NASH
Cirrhosis of the liver is a progressive disease, developing slowly over many years. If allowed to continue, the buildup of scar tissue can eventually stop liver function. Because of the gradual decline, liver cirrhosis often goes undetected and unnoticed. You …
August 26, 2021 | By John Raslavsky | Cirrhosis, Clinical Trials, Liver Disease | Blog, NAFLD, NASH
Cirrhosis is when the permanent scarring of the liver has replaced the healthy tissue. While cirrhosis is most often associated with chronic alcohol consumption, it is brought about by many types of liver disease. Here’s how you get from liver disease …
December 15, 2020 | By John Raslavsky | Cirrhosis, Clinical Trials | Blog, Clinical research, Fatty Liver Disease, Liver disease
Cirrhosis is the replacement of healthy liver tissue with non-living scar tissue. It is a complication of liver disease from the progressive damage caused if not treated. Most people have no symptoms in the early stages, where the progression …